Počet záznamů: 1
Administration of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and diclofenac in the combination attenuates their anti-tumor activities
- 1.0126930 - BFU-R 20033011 RIV SK eng J - Článek v odborném periodiku
Fedoročko, P. - Hoferová, Zuzana - Hofer, Michal - Brezáni, P.
Administration of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and diclofenac in the combination attenuates their anti-tumor activities.
Neoplasma. Roč. 50, č. 3 (2003), s. 176-184. ISSN 0028-2685. E-ISSN 1338-4317
Grant CEP: GA AV ČR IBS5004009; GA AV ČR KSK5011112
Grant ostatní: VEGA MŠ SR(SK) 1/9211/02
Výzkumný záměr: CEZ:AV0Z5004920
Klíčová slova: muramyl tripeptide * diclofenac * NSAIDs
Kód oboru RIV: BO - Biofyzika
Impakt faktor: 0.782, rok: 2003
Liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE), an immunomodulator, and diclofenac, an inhibitor of prostaglandin production, were shown earlier to have anti-tumour effects. In the experiments described in this communication it was shown that combined treatment of mice bearing fibrosarcoma tumours with the above two substances attenuated their anti-tumour activities.
Trvalý link: http://hdl.handle.net/11104/0025157
Počet záznamů: 1